People · Operator
Named in public records as an officer, director or promoter · active 2014–2022 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Novamind Inc. | — | Biotechnology | Series A | $9.1M | $66.6M | 2020 |
| Tweed Marijuana Inc. | — | Pharmaceuticals | Seed | $1.8M | $69.4M | 2014 |
Charles Rifici at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Rifici on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bruce Linton | 1 | 4 |
| Reid Robison | 1 | 4 |
| Chris Schnarr | 1 | 4 |
| Ingrid Martin | 1 | 3 |
| Yaron Conforti | 1 | 3 |
| Jesse Kaplan | 1 | 3 |
| PETER THIERSCH | 1 | 3 |
| Jing Peng | 1 | 2 |
| Greg Fekete | 1 | 2 |
| Mark Fekete | 1 | 2 |
| Vaughn MacLellan | 1 | 2 |
| Yisroel Weinreb | 1 | 2 |
| Gerald Leahy | 1 | 1 |
| Mark Zekulin | 1 | 1 |
| Andrew Moffat | 1 | 1 |
| Larry Poirier | 1 | 1 |
| Dr. Reid Robison | 1 | 1 |
| Paul Thielking | 1 | 1 |
| Nolan Ladouceur | 1 | 1 |
| Seneca Anderson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.